No headlines found.
No press releases found.
No news found.
Invests in stocks in the S&P MidCap 400 Growth Index composed of the growth companies in the S&P 400. Focuses on closely tracking the index s return which is considered a gauge of overall U.S. mid-cap growth stock returns. Offers high potential for investment growth; share value rises and falls more sharply than that of funds holding bonds. More appropriate for long-term goals where your money s growth is essential.
Vanguard S&P Mid-Cap 400 Growth ETF trades on the ARCA stock market under the symbol IVOG.
As of April 2, 2026, IVOG stock price declined to $126.35 with 7,957 million shares trading.
IVOG has a beta of 0.94, meaning it tends to be less sensitive to market movements. IVOG has a correlation of 0.75 to the broad based SPY ETF.
IVOG has a market cap of $1.44 billion. This is considered a Small Cap stock.
In the last 3 years, IVOG traded as high as $134.28 and as low as $84.56.
IVOG has outperformed the market in the last year with a price return of +22.0% while the SPY ETF gained +17.9%. IVOG has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +5.1% and +0.7%, respectively, while the SPY returned -3.8% and -0.8%, respectively.
IVOG support price is $124.18 and resistance is $128.88 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IVOG shares will trade within this expected range on the day.
